Skip to main content
Log in

Effect of antisense oligonucleotides targeting telomerase catalytic subunit on tumor cell proliferationin vitro

  • Notes
  • Published:
Chinese Science Bulletin

Abstract

To screen specific antitumor drugs targeting telomerase catalytic subunit (hEST2), 12 differenthEST2 antisense oligonucleotides were designed based on hEST2 mRNA second structure and transfected into tumor cell lines by the lipofectin-mediated method. Cell growth activity was evaluated by MTT assay.hEST212 was picked out and its specificity, antitumor tree and continuous effect were analyzed. The results showed thathEST212 had promising antitumor activityin vitro, hEST2 can be used as a pratical target and an antisense drug candidate for cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blackburn, E. H., Telomeres, Trends Biol. Sci., 1991, 16: 378.

    Article  CAS  Google Scholar 

  2. Hastie, N. D., Dempster, M., Dunlop, M. G. et al., Telomere reduction in human colorectal cancinoma and with ageing, Nature, 1990; 346: 866.

    Article  PubMed  CAS  Google Scholar 

  3. Kim, N. W., Piatyszek, M. A., Prowse, K. R. et al., Specific association of human telomerase activity with immortal cells and cancer, Science, 1994, 266: 2011.

    Article  PubMed  CAS  Google Scholar 

  4. Piatyszek, M. A., Kim, N. W., Weinrich, S. L. et al., Detection of telomerase activity in human cells and tumors, Meth. Cell Sci., 1995, 17: 1.

    Article  Google Scholar 

  5. Counter, C. M., Hirte, H. W., Baccetti, S. et al., Telomerase activity in human ovarian cancinoma, Proc. Natl. Acad. Sci. USA, 1994, 91: 2900.

    Article  PubMed  CAS  Google Scholar 

  6. Strahl, C., Blackburn, E. H., Effect of reverse transcriptase inhibition on telomere length and telomerase activity in two immortalized human cell lines, Mol. Cell Biol., 1996, 16: 53.

    PubMed  CAS  Google Scholar 

  7. Strahl, C., Blackburn, E. H., The effects of nucleoside analogs on telomerase and telomeres in tetrahymena, Nucleic Acids Res., 1994, 22: 893.

    Article  PubMed  CAS  Google Scholar 

  8. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L. et al., The RNA component of human telomerase, Science, 1995, 269: 1236.

    Article  PubMed  CAS  Google Scholar 

  9. Norton, J. C., Piatyszek, M. A., Wright, W. E. et al., Inhibition of human telomerase activity by peptide nucleic-acides, Nature Biotechnol., 1996, 14: 615.

    Article  CAS  Google Scholar 

  10. Meyerson, M., Couner, C. M., Eaton, E. N. et al.,hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization, Cell, 1997, 90: 785.

    Article  PubMed  CAS  Google Scholar 

  11. Tahara, H., Yasui, W., Tahara, E. et al., Immunohistochemical detection of human telomerase catalytic component,hEST2, in human colorectal tumor and non-tumor tissue sections, Oncogene, 1999, 18: 1561.

    Article  PubMed  CAS  Google Scholar 

  12. Counter, C. M., Meyerson, M., Eaton, E. N. et al., Telomerase activity is restored in human cells by ectopic expression ofhEST2 (hEST2), the catalytic subunit of telomerase, Oncogene, 1998, 16: 1217.

    Article  PubMed  CAS  Google Scholar 

  13. Allsopp, R. C., Telomere length predicts replicative capacity of human fibroblasts, Proc. Natl. Acad. Sci. USA, 1992, 89: 10114.

    Article  PubMed  CAS  Google Scholar 

  14. Shay, J. W., Wright, W. E., Werbin, H., Defining the molecular mechanism of human cell immortalization, Biochim. Biophys. Acta, 1991, 1072: 1.

    PubMed  CAS  Google Scholar 

  15. Shay, J. W., Werbin, H., Wright, W. E., Telomeres and telomerase in human leukemias, Leukemia, 1996, 10: 1255.

    PubMed  CAS  Google Scholar 

  16. Allsopp, R. C., Harley, C. B., Evidence of a critical telomere length in senescent human fibroblasts, Exp. Cell Res., 1995, 219: 130.

    Article  PubMed  CAS  Google Scholar 

  17. Harley, C. B., Telomeres and aging: fact, fancy, and the future, J. NIH Res., 1995, 7: 64.

    Google Scholar 

  18. Meyerson, M., Counter, C. M., Eaton, E. N. et al.,hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cell and during immortalization, Cell, 1997, 90: 785.

    Article  PubMed  CAS  Google Scholar 

  19. Shaw, J. P., Kent, K., Bird, J. et al., Modified oligodeoxynucleotides stable to exonuclease degradation in serum, Nucleic Acids Res., 1991, 19: 747.

    Article  PubMed  CAS  Google Scholar 

  20. Stein, C. A., Cohen, J. S., Oligodeoxynucleotides as inhibitors of gene expression: A review, Cancer Res., 1988, 48: 2659.

    CAS  Google Scholar 

  21. Kondo, S., Kondo, Y., Li, G. Y. et al., Targeted therapy of human malignant glioma in a mouse model by 2–5A antisense directed against telomerase RNA, Oncogene, 1998, 16: 3320120.

    Google Scholar 

  22. Mandai, M., Kumar, R., Bcl-2 modulates telomerase activity, J. Biol. Chem., 1997, 272: 14183.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shengqi Wang.

About this article

Cite this article

Wang, S., Lin, L., Chen, Z. et al. Effect of antisense oligonucleotides targeting telomerase catalytic subunit on tumor cell proliferationin vitro . Chin. Sci. Bull. 47, 993–997 (2002). https://doi.org/10.1007/BF02907568

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02907568

Keywords

Navigation